Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Running at 40% - on2u
1
Apr 28, 2008 09:09AM

Apr 28, 2008 10:26AM

Re: "The February signings should also be in the Q report."

Why?

That could happen only if their last Q report was manipulated to increase earnings in future Q. I don't think that's allowed.

Share
New Message
Please login to post a reply